Published

Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Frontiers in psychiatry
Date: 2023-01-01
Source: PubMed
DOI: 10.3389/fpsyt.2023.1199642
PubMed: 37795509

Authors

Nayak SM Jackson H Sepeda ND Mathai DS So S Yaffe A Zaki H Brasher TJ Lowe MX Jolly DRP Barrett FS Griffiths RR Strickland JC Johnson MW Garcia-Romeu A

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Wellbeing Emotional Processing Spirituality Mystical Experience Observational Study Observational Study

Citation graph

0 referenced DOIs found in stored source metadata. 6 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement2026-12-01 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms2026-07-01 Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA2026-06-15 Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization2026-05-13 Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.2023-01-01

Related papers

Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding StudyClinicalTrials.gov · 2023-03-20 The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy AdultsClinicalTrials.gov · 2026-06-02 Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of PsilocybinClinicalTrials.gov · 2026-07-29 Consciousness and Psilocybin Effects on Well-Being: The CoPEWell StudyClinicalTrials.gov · 2026-07-02 Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot PhaseClinicalTrials.gov · 2025-05-16 Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult VolunteersClinicalTrials.gov · 2023-05-19 Safety for Home Administration of Microdose Psilocybin UseClinicalTrials.gov · 2026-08-14 Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05